Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Thesla Palanee‐Phillips et al.|New England Journal of Medicine|2016Cited by 768
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Thesla Palanee‐Phillips et al.|Obstetrical & Gynecological Survey|2016Cited by 373
Favoring “Peace of Mind”: A Qualitative Study of African Women's HIV Prevention Product Formulation Preferences from the MTN-020/ASPIRE TrialAriane van der Straten, Felix Mhlanga, Mary Kate Shapley‐Quinn et al.|AIDS Patient Care and STDs|2017Cited by 46
Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III TrialThesla Palanee‐Phillips, Sarah T. Roberts, Krishnaveni Reddy et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2018Cited by 44
Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort StudyKathryn Peebles, Felix Mhlanga, Arendevi Pather et al.|Clinical Infectious Diseases|2020Cited by 44